Премини към основното съдържание
Home
language-selector-globe Bulgaria | bg
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Bulgaria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • За нас 
      • Новартис в България 
      • Нашата стратегия 
        • Иновативни лекарства 
      • Хора и Култура 
      • Контакти 
      За нас За нас
    • Пациенти и болногледачи 
      • Аз само да попитам: твоят здравен консултант 
      • Ангажиментът на Новартис към пациентите и лицата, които се грижат за тях 
      • Съобщаване на нежелани реакции 
      • Аз само да попитам: твоят здравен портал 
      Пациенти и болногледачи Пациенти и болногледачи
    • Здравни специалисти 
      • Материали за здравни специалисти 
      • Новартис проекти 
      • Съобщаване на нежелани реакции 
      • Клинични проучвания на Новартис 
      Здравни специалисти Здравни специалисти
    • ESG 
      • Етика, Риск и Законосъобразност 
      • Разширяване на достъпа до здравеопазване 
      • Опазване на природата 
      • Световно здраве 
      • Етично поведение 
        • Етичен кодекс 
        • SpeakUp 
      Околна среда, социални и правни въпроси ESG
    • Новини 
      • Медийни контакти 
      • Новини 
      Новини Новини
    • Кариера 
      • Търсене на кариера 
      • Награди и признание 
      Кариера Кариера
    • Коронавирус 
      Коронавирус Коронавирус
    Новартис България Начало
  1. Начало
  2. Кариера
  3. Търсене на кариера
  • Sort by Sort ascending
  • Длъжност
  • Място
  • Местоположение
  • дивизия
  • Бизнес Sort ascending
  • Functional Area
  • Дата
Длъжност Място Местоположение дивизия Бизнес Sort ascending Functional Area Дата
R2R Team Lead - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Окт. 10, 2024
Sr. Spec. DDIT GF Sol.Del. HCM Hyderabad (Office) India Operations CTS Technology Transformation Окт. 10, 2024
UX/UI Designer Prague Czech Republic Operations CTS Technology Transformation Окт. 10, 2024
LDC - Data Business Manager - Operations Prague Czech Republic Operations CTS Technical Operations Окт. 10, 2024
Associate Director of Forensics Hyderabad (Office) India Operations CTS Technology Transformation Окт. 10, 2024
Assoc. Dir. Solution Delivery - SAP FICO Barcelona Gran Vía Spain Operations CTS Technology Transformation Окт. 10, 2024
Director, Marketing & Digital Data Solution Hyderabad (Office) India Operations CTS Marketing Окт. 10, 2024
Director Data Stratagy Hyderabad (Office) India Operations CTS Marketing Окт. 10, 2024
Sr. Spec. DDIT IES Projects Hyderabad (Office) India Operations CTS Technology Transformation Окт. 10, 2024
Sr. Spec. DDIT IES Projects Hyderabad (Office) India Operations CTS Technology Transformation Окт. 10, 2024
Legal Trainee - Legal Procurement, Data/Digital & IT Basel (City) Switzerland Legal CTS Others Окт. 10, 2024
Solution Delivery- SAP SME (BTP & CPI) Prague Czech Republic Operations CTS Technology Transformation Окт. 10, 2024
Senior Analyst, Product Management Hyderabad (Office) India Operations CTS Marketing Окт. 10, 2024
Snr. Specialist SAP BASIS / AWS Cloud INSURGENTES Mexico Operations CTS Technology Transformation Септ. 30, 2024
Head DDIT IES Infrastructure Solutions Hyderabad (Office) India Operations CTS Technology Transformation Окт. 01, 2024
Lean Digital Core - Project Manager Commercial Prague Czech Republic Operations CTS Technology Transformation Окт. 02, 2024
PS&S Engagement Services Expert INSURGENTES Mexico People & Organization CTS Human Resources Окт. 16, 2024
Human Resources Specialist (5 Temporary roles -12 months) INSURGENTES Mexico People & Organization CTS Human Resources Окт. 16, 2024
Manager Economic Modelling Hyderabad (Office) India Operations CTS Market Access Окт. 16, 2024
Vodja Finančne skladnosti in kontrol Slovenija (m/ž/d) / Financial Control and Compliance Lead Slovenia (m/f/d) Ljubljana Slovenia Finance CTS Audit & Finance Окт. 17, 2024
Manager, Analytical Product Services Hyderabad (Office) India Operations CTS Marketing Окт. 17, 2024
IT Business Partner Director for Clinical Development Barcelona Gran Vía Spain Operations CTS Technology Transformation Окт. 17, 2024
Manager, Analytical Product Services Hyderabad (Office) India Operations CTS Marketing Окт. 17, 2024
R2R Accountant Moscow (City) Russian Fed. Finance CTS Audit & Finance Окт. 22, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Май 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Май 20, 2024
Treasury Manager Moscow (City) Russian Fed. Finance CTS Audit & Finance Юни 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Май 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Май 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Май 20, 2024
Procure to Pay Senior Specialist MR11 INSURGENTES Mexico Finance CTS Audit & Finance Юли 23, 2024
Order to Cash Radioligand Therapy Sr. Specialist INSURGENTES Mexico Finance CTS Audit & Finance Авг. 06, 2024
LDC Adopt Process Lead - Taxes INSURGENTES Mexico Operations CTS Audit & Finance Авг. 19, 2024
TCM Senior Cash Management Specialist INSURGENTES Mexico Operations CTS Audit & Finance Авг. 30, 2024
Record to Report Specialist INSURGENTES Mexico Finance CTS Audit & Finance Септ. 05, 2024
Record to Report Sr Specialist INSURGENTES Mexico Operations CTS Audit & Finance Септ. 10, 2024
Record to Report Sr Specialist Intercompany INSURGENTES Mexico Operations CTS Audit & Finance Септ. 10, 2024
Record to Report Sr Specialist US INSURGENTES Mexico Operations CTS Audit & Finance Септ. 10, 2024
Fixed Assets Sr Specialist INSURGENTES Mexico Operations CTS Audit & Finance Септ. 10, 2024
Buyer LACan (Temporary) INSURGENTES Mexico Operations CTS Procurement Септ. 15, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Май 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Май 20, 2024
Senior Specialist DDIT ISC Detection & Response Hyderabad (Office) India Operations CTS Technology Transformation Окт. 17, 2024
Sr. Specialist DDIT ISC Detection & Response Hyderabad (Office) India Operations CTS Technology Transformation Окт. 17, 2024
Interim HR System Expert Milano Italy People & Organization CTS Human Resources Окт. 17, 2024
Associate, Record-to-Report Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit & Finance Юни 26, 2024
Senior Specialist DDIT OPS Mfg Site IT Sasayama Japan Operations CTS Information Technology Юли 22, 2024
Manager, Financial Control & Compliance (FC&C) Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit & Finance Окт. 06, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Май 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Май 20, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • › Next page

Новартис България

Навигация
  • Пациенти и болногледачи
  • Здравни специалисти
  • ESG
  • Новини
  • Кариера
Медиен център
  • Архив
  • Новини
Нашето портфолио
  • Клинични проекти на Новартис
Други сайтове на Новартис
  • Глобален сайт
Footer Bottom
© 2024 Новартис АГ
  • Политика за поверителност
  • Условия на ползване
  • Достъп от мрежата
  • Настройки за бисквитки
  • Навигация на сайта
Директория на сайта на Новартис
Тази страница е предназначена за обществеността в България